EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H24NS2 |
| Net Charge | +1 |
| Average Mass | 330.542 |
| Monoisotopic Mass | 330.13447 |
| SMILES | [H][C@]12CCCC[N@+]1(C)CC(=C(c1cccs1)c1cccs1)CC2 |
| InChI | InChI=1S/C19H24NS2/c1-20-11-3-2-6-16(20)10-9-15(14-20)19(17-7-4-12-21-17)18-8-5-13-22-18/h4-5,7-8,12-13,16H,2-3,6,9-11,14H2,1H3/q+1/t16-,20-/m1/s1 |
| InChIKey | ZGSDGGRVFIYKKE-OXQOHEQNSA-N |
| Roles Classification |
|---|
| Biological Role: | muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. |
| Applications: | muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. antispasmodic drug A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder. anti-ulcer drug One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tiquizium (CHEBI:145714) has role anti-ulcer drug (CHEBI:49201) |
| tiquizium (CHEBI:145714) has role antispasmodic drug (CHEBI:53784) |
| tiquizium (CHEBI:145714) has role muscarinic antagonist (CHEBI:48876) |
| tiquizium (CHEBI:145714) is a quaternary ammonium ion (CHEBI:35267) |
| tiquizium (CHEBI:145714) is a quinolizines (CHEBI:38063) |
| tiquizium (CHEBI:145714) is a thiophenes (CHEBI:26961) |
| Incoming Relation(s) |
| tiquizium bromide (CHEBI:32232) has part tiquizium (CHEBI:145714) |
| IUPAC Name |
|---|
| (5R,9aR)-3-[di(thiophen-2-yl)methylidene]-5-methyloctahydro-2H-quinolizinium |
| Synonyms | Source |
|---|---|
| (5R,9aR)-3-[di(thiophen-2-yl)methylidene]-5-methyloctahydro-2H-quinolizin-5-ium | IUPAC |
| trans-3-(di-2-thienylmethylene)octahydro-5-methyl-2H-quinolizinium | ChemIDplus |
| 3-(di-2-thienylmethylene)-octahydro-5-methyl-trans-quinolizinium | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 2678 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:149755-23-7 | ChemIDplus |
| Citations |
|---|